| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |